標(biāo)題: Titlebook: Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis; Albert V. G. Bruschke,Johan H. C. Reiber,Hein J. J Book 1996 Kluwer Ac [打印本頁(yè)] 作者: AMASS 時(shí)間: 2025-3-21 19:32
書(shū)目名稱Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis影響因子(影響力)
書(shū)目名稱Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis影響因子(影響力)學(xué)科排名
書(shū)目名稱Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis被引頻次
書(shū)目名稱Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis被引頻次學(xué)科排名
書(shū)目名稱Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis年度引用
書(shū)目名稱Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis年度引用學(xué)科排名
書(shū)目名稱Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis讀者反饋
書(shū)目名稱Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis讀者反饋學(xué)科排名
作者: Mere僅僅 時(shí)間: 2025-3-21 22:18 作者: 我就不公正 時(shí)間: 2025-3-22 03:55
Quality control in quantitative coronary arteriographytill room for further improvements. Therefore, for new studies, maximal attention should be given to these and other items, not only at the start of the study, but also during the course of the trial.作者: 形容詞 時(shí)間: 2025-3-22 04:49 作者: 就職 時(shí)間: 2025-3-22 10:34
Book 1996spects, including biochemical as well asangiographic aspects, are discussed by experts in these fields. Acareful comparison of all available data permits an analysis to bemade of what may currently be considered proved, which aspects meritfurther investigation, and which hypotheses should be rejecte作者: uncertain 時(shí)間: 2025-3-22 13:33
0166-9842 ological aspects, including biochemical as well asangiographic aspects, are discussed by experts in these fields. Acareful comparison of all available data permits an analysis to bemade of what may currently be considered proved, which aspects meritfurther investigation, and which hypotheses should 作者: 谷類(lèi) 時(shí)間: 2025-3-22 19:30 作者: hypnotic 時(shí)間: 2025-3-22 23:55 作者: Morbid 時(shí)間: 2025-3-23 02:10 作者: 只有 時(shí)間: 2025-3-23 05:54 作者: 領(lǐng)袖氣質(zhì) 時(shí)間: 2025-3-23 12:24 作者: 果核 時(shí)間: 2025-3-23 14:53
Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis978-94-009-0143-8Series ISSN 0166-9842 作者: 苦笑 時(shí)間: 2025-3-23 20:36
Angiographic endpoints in progression trials, this is an avoidable problem and therefore a serious attempt at standardization should be made. This chapter reviews the criteria which have been used in trials using quantitative coronary angiography and presents a proposal for standardization.作者: Enzyme 時(shí)間: 2025-3-24 01:29
The Cholesterol Lowering Atherosclerosis Study (CLAS)al to conclusively demonstrate the angiographic benefit of lipid lowering therapy, first at two and subsequently more pronounced at four years. Recently, long-term clinical follow-up has been completed.作者: 雪上輕舟飛過(guò) 時(shí)間: 2025-3-24 05:04
Effects of the lipid intervention in the Stanford Coronary Risk Intervention Projectge from entry to four-year follow-up angiograms in minimum lumen diameter of diseased segments in 245 subjects was analysed in relation to hypolipidaemic medication and lipid-related risk factors. Greater disease progression was associated with non-use of hypolipidaemic drugs and higher blood glucose and insulin levels.作者: 現(xiàn)任者 時(shí)間: 2025-3-24 10:22 作者: 謙卑 時(shí)間: 2025-3-24 11:24
https://doi.org/10.1007/978-94-009-0143-8Bypass; Lipoprotein; atherosclerosis; coronary artery disease; coronary heart disease作者: 處理 時(shí)間: 2025-3-24 18:22 作者: Hormones 時(shí)間: 2025-3-24 20:49 作者: Lethargic 時(shí)間: 2025-3-25 01:28
1997, 1999b) both highlight the extent to which the decision to establish foreign subsidiaries is influenced by the need to appropriate the rents accruing from investment in firm-specific knowledge-based assets and practices. Many new theoretical models also view the creation and exploitation of kn作者: 貪婪的人 時(shí)間: 2025-3-25 03:42 作者: expdient 時(shí)間: 2025-3-25 09:04
H. Buchwald,C. T. Camposirect investment (FDI) into the EU (IBB, 1993). The theory of FDI points to many reasons why countries would wish to attract inward investment, going well beyond direct employment effects. Theory assumes that, in general, in order to prosper in a foreign environment the firm must possess some ‘owner作者: Cholecystokinin 時(shí)間: 2025-3-25 12:04
irect investment (FDI) into the EU (IBB, 1993). The theory of FDI points to many reasons why countries would wish to attract inward investment, going well beyond direct employment effects. Theory assumes that, in general, in order to prosper in a foreign environment the firm must possess some ‘owner作者: peritonitis 時(shí)間: 2025-3-25 16:59
G. F. Wattsirect investment (FDI) into the EU (IBB, 1993). The theory of FDI points to many reasons why countries would wish to attract inward investment, going well beyond direct employment effects. Theory assumes that, in general, in order to prosper in a foreign environment the firm must possess some ‘owner作者: Customary 時(shí)間: 2025-3-25 23:42
J. H. C. Reiber,J. W. Jukema,G. Koning,A. V. G. Bruschkeirect investment (FDI) into the EU (IBB, 1993). The theory of FDI points to many reasons why countries would wish to attract inward investment, going well beyond direct employment effects. Theory assumes that, in general, in order to prosper in a foreign environment the firm must possess some ‘owner作者: 大范圍流行 時(shí)間: 2025-3-26 01:22
L. Cashin-Hemphillerbreitetste und heftigste sexuelle Verlangen beim Menschen ist. In allen menschlichen Kulturen würde nun dieses Verlangen durch das Inzestverbot unterdrückt. Es werden verschiedene Gründe dafür angegeben, warum das Inzestverbot existiert. Es soll verhindern, da? sexuelle Rivalit?ten und Eifersucht 作者: conceal 時(shí)間: 2025-3-26 07:28
A. V. G. Bruschke,J. W. Jukema,A. J. Van Boven,E. T. Bal,J. H. C. Reiber,A. H. Zwindermanerbreitetste und heftigste sexuelle Verlangen beim Menschen ist. In allen menschlichen Kulturen würde nun dieses Verlangen durch das Inzestverbot unterdrückt. Es werden verschiedene Gründe dafür angegeben, warum das Inzestverbot existiert. Es soll verhindern, da? sexuelle Rivalit?ten und Eifersucht 作者: artless 時(shí)間: 2025-3-26 11:27 作者: Cholagogue 時(shí)間: 2025-3-26 16:31
L. Cashin-Hemphillwangerschap een uitvoerig gesprek plaatsvinden. Voor pati?nten met een ernstige nierinsuffici?ntie zal dit overleg veelal plaatsvinden met de behandelend nefroloog, en zal een preconceptioneel advies gevraagd worden aan de gynaecoloog-obstetricus. Pati?nten met geringe nierschade of pati?nten met ni作者: Brain-Waves 時(shí)間: 2025-3-26 16:52
J. W. Jukema,A. J. Van Boven,J. H. C. Reiber,A. H. Zwinderman,K. I. Lie,A. V. G. Bruschkewangerschap een uitvoerig gesprek plaatsvinden. Voor pati?nten met een ernstige nierinsuffici?ntie zal dit overleg veelal plaatsvinden met de behandelend nefroloog, en zal een preconceptioneel advies gevraagd worden aan de gynaecoloog-obstetricus. Pati?nten met geringe nierschade of pati?nten met ni作者: surrogate 時(shí)間: 2025-3-26 21:05 作者: Cpr951 時(shí)間: 2025-3-27 01:30 作者: 人類(lèi)的發(fā)源 時(shí)間: 2025-3-27 06:21 作者: 規(guī)章 時(shí)間: 2025-3-27 11:04
The use of metabolic measurements in angiographic regression trialstherapeutic interventions and to generate new hypotheses concerning the determinants of coronary atherosclerosis. All analytical and biological sources of variation should be minimized, with consistent use of quality control material and, ideally, a reference laboratory. Potential confounders in stu作者: 未完成 時(shí)間: 2025-3-27 16:57
Quality control in quantitative coronary arteriographyand later by quantitative coronary arteriography (QCA), sometimes supported by visual interpretation. The higher accuracy and precision of the computer-aided approach, however, can only be achieved under highly standardized circumstances. An overview is given on the necessary precautions to be taken作者: tendinitis 時(shí)間: 2025-3-27 21:14 作者: 貞潔 時(shí)間: 2025-3-28 00:08 作者: Instantaneous 時(shí)間: 2025-3-28 05:09 作者: glucagon 時(shí)間: 2025-3-28 06:34 作者: IOTA 時(shí)間: 2025-3-28 10:58 作者: 極深 時(shí)間: 2025-3-28 17:09 作者: Impugn 時(shí)間: 2025-3-28 18:59 作者: mechanism 時(shí)間: 2025-3-29 01:46
The St Thomas’ Atherosclerosis Regression Study and an appraisal of its potential limitationsoint blinded study of the effects of lipid-lowering therapy on angiographic coronary artery disease (CAD) in male patients with hypercholesterolemia. Both a fat-modified diet and diet-plus cholestyramine favourably influenced the course of CAD over 3 years. As discussed in this paper, the study did,作者: 詩(shī)集 時(shí)間: 2025-3-29 03:08 作者: MAL 時(shí)間: 2025-3-29 09:25 作者: 終點(diǎn) 時(shí)間: 2025-3-29 11:54
Impact upon angiographic disease progression following step drug therapy in normolipidaemic patients potential benefit of drug therapy in normocholesterolaemic patients has not been examined in a randomized prospective fashion. Patients with symptomatic coronary artery disease with at least one lesion narrowed by >30% were randomized to either placebo (. = 39), or stepped drug therapy using pravas作者: happiness 時(shí)間: 2025-3-29 17:17
L. Campeau,J. Lespérance,D. Waters,CCAIT Investigators作者: 捕鯨魚(yú)叉 時(shí)間: 2025-3-29 19:52 作者: MOTIF 時(shí)間: 2025-3-30 01:49 作者: Cleave 時(shí)間: 2025-3-30 04:24 作者: CREEK 時(shí)間: 2025-3-30 12:11 作者: sebaceous-gland 時(shí)間: 2025-3-30 15:42 作者: V切開(kāi) 時(shí)間: 2025-3-30 19:25 作者: ARCH 時(shí)間: 2025-3-30 22:58
Impact upon angiographic disease progression following step drug therapy in normolipidaemic patientsseline minimum lumen diameter for both groups was 1.6 ±0.7 mm which worsened over a mean of 2.5 years by 0.14±0.42mm (.<0.0001) in the treatment group and by 0.15±0.41 mm (.<0.0001) in the control group. Baseline percent stenosis for both groups was 47 ± 13% which worsened in the treatment group by 作者: 使成整體 時(shí)間: 2025-3-31 04:13 作者: initiate 時(shí)間: 2025-3-31 07:38
chapter we present new evidence on the impact of inward investment on technical progress, and hence labour productivity and growth, in a number of different UK industries. We utilise two different data sets and a number of different estimation techniques in an attempt to assess the robustness of ou
